Green Thumb Industries (GTBIF) Interest & Investment Income (2019 - 2026)
Green Thumb Industries' (GTBIF) quarterly Interest & Investment Income came in at $4.6 million in Q1 2026, up 116.82% YoY from $2.1 million in Q1 2025, and up 13.82% on a QoQ basis from $4.0 million in Q4 2025.
Green Thumb Industries (GTBIF) Interest & Investment Income (2019 - 2026) Analysis & Trends
Green Thumb Industries (GTBIF) has 8 years of Interest & Investment Income data on file, last reported at $4.6 million in Q1 2026.
- Quarterly Interest & Investment Income rose 116.82% year-over-year to $4.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $13.9 million (up 52.38% YoY) and the FY2025 annual result came in at $11.4 million, up 25.38% from the prior year.
- Interest & Investment Income advanced to $4.6 million in Q1 2026, from $4.0 million in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $4.6 million in Q1 2026 to a low of $624000.0 in Q2 2022.
- A 5-year average of $2.1 million and a median of $1.9 million in 2025 frame the typical range for Interest & Investment Income.
- Annual changes were most pronounced in 2022 — Interest & Investment Income soared 1700.0% — and 2025, when it retreated 17.46%.
- Tracing GTBIF's Interest & Investment Income over 5 years: stood at $1.5 million in 2022, then gained by 27.24% to $1.9 million in 2023, then increased by 7.15% to $2.0 million in 2024, then surged by 103.01% to $4.0 million in 2025, then rose by 13.82% to $4.6 million in 2026.
- The last three Interest & Investment Income figures came in at $4.6 million (Q1 2026), $4.0 million (Q4 2025), and $3.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.92 Bn | 42.96 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.19 Bn | 39.53 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.74 Bn | 30.06 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.67 Bn | 22.87 Bn | 5.10 Bn | 154.39 Mn |
| 5 | United Therapeutics | 22.22 Bn | 19.56 Bn | 683.80 Mn | 31.50 Mn |
| 6 | Viatris | 18.71 Bn | 17.83 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.55 Bn | 15.16 Bn | 935.80 Mn | 12.40 Mn |
| 8 | Elanco Animal Health | 11.80 Bn | 11.27 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | - |
| 10 | Green Thumb Industries | 1.66 Bn | 1.37 Bn | 137.87 Mn | 4.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.30 Mn |
| Mar 31, 2026 | 4.60 Mn |
| Dec 31, 2025 | 4.04 Mn |
| Sep 30, 2025 | 3.30 Mn |
| Jun 30, 2025 | 1.91 Mn |
| Mar 31, 2025 | 2.12 Mn |
| Dec 31, 2024 | 1.99 Mn |
| Sep 30, 2024 | 2.67 Mn |
| Jun 30, 2024 | 2.31 Mn |
| Mar 31, 2024 | 2.10 Mn |
| Dec 31, 2023 | 1.86 Mn |
| Sep 30, 2023 | 1.58 Mn |
| Jun 30, 2023 | 1.53 Mn |
| Mar 31, 2023 | 1.73 Mn |
| Dec 31, 2022 | 1.46 Mn |
| Sep 30, 2022 | 1.09 Mn |
| Jun 30, 2022 | 624,000.00 |
| Mar 31, 2022 | 900,000.00 |
| Dec 31, 2021 | 758,000.00 |
| Sep 30, 2021 | 328,000.00 |